Uncategorized
Research Events and Deadlines (October 2026)
Neuroscientist Bevil Conway will give the keynote lecture at the McPherson ERI’s 18th Annual Vision Science Symposium (MERI) – Oct. 15 Conway, directs the Section on Perception, Cognition, and Action at the Laboratory of Sensorimotor Research, at the National Eye Institute. His lab studies cortical object representation, with a focus on…
Research news roundup (October 2026)
Neugebauer Receives High Risk, High Reward New Innovator Award With support from the National Institutes of Health 2026 High Risk, High Reward New Innovator Awards, University of Wisconsin–Madison biochemistry professor Monica Neugebauer is exploring nickel-dependent enzymes that can drive new-to-nature chemical reactions. Neugebauer’s lab focuses on discovering and engineering…
New federal policy affecting life sciences research goes into effect Jan. 1, 2027
In late July, the federal government released a new U.S. Government Policy for Stopping High-Risk Life Sciences Research pursuant to Executive Order 14292 (Improving the Safety and Security of Biological Research). This policy significantly broadens the scope of life sciences research that must be assessed for potential impact to national…
2027 Bassam Z. Shakhashiri Public Science Engagement Award
Bassam Shakhashiri/Photo by Jeff Miller, UW–Madison About the Competition The Bassam Z. Shakhashiri Public Science Engagement Award recognizes one University of Wisconsin–Madison faculty and one academic staff member who has shown excellence in engaging the public in their work in STEAM (Science, Technology, Engineering, Arts and Math) research.
Research News Roundup for September
Waisman investigators receive NIH funding to optimize the use of brain organoids in research By Charlene N. Rivera-Bonet A newly funded project will combine the expertise of four Waisman Center investigators – Daifeng Wang, PhD, H.I. Romnes Associate Professor of biostatics and medical informatics, and computer sciences, Xinyu Zhao,…
Research Events and Deadlines( September 2026 issue)
Interested in STEM careers involving teaching or community engagement? Transform your passion into impact as a WISCIENCE Fellow — applications open Sept. 14 If you’re a STEM graduate student or postdoctoral scholar at UW–Madison looking to expand your reach beyond the lab, WISCIENCE offers three immersive, year-long Fellows…
First drug to treat Alexander disease just approved by the FDA after three decades of research at UW–Madison
By Charlene N. Rivera-Bonet The U.S. Food and Drug Administration (FDA) recently approved the first drug to treat Alexander disease, a rare, progressive, and often fatal neurological disorder that can affect motor, cognitive, autonomic, and gastrointestinal functions. The drug, Zanvastro, is the first and only disease modifying treatment for…
Inaugural Microbiome Symposium Showcased Interdisciplinary Work Enabled by Campus Germ-Free Mouse Facility
By Martel DenHartog, Tiny Earth Chemistry Hub Manager, Handelsman Lab, Wisconsin Institute for Discovery Last spring, over 130 scientists spanning 40+ departments convened for the inaugural UW–Madison Microbiome Symposium. Speakers highlighted research efforts enabled by the new Gnotobiotic Shared Resource (GSR), a centralized germ-free and gnotobiotic mouse research support facility established with a…